Webinar: Customized Central Laboratory Services for Support of Global Clinical Trials: PBMC Processing

In North America: Wednesday, 14 September 2022 at Noon EDT / 900 PDT (register here)

In Europe:  Wednesday, 14 September 2022 at Noon BST / 1300 CEST (register here)

Central laboratory service (CLS) providers offer a range of operational capabilities to accelerate drug development programs and support global clinical trial needs. From routine peripheral blood mononuclear cell (PBMC) processing to more complex genomic, proteomic, and cellular analyses, CLS providers deliver consistent quality-controlled sample handling and processing services to meet the demanding needs of innovative clinical research.  In this webinar, we will provide insight into the role of the central laboratory in general and provide an overview of the customized CLS approach offered by REPROCELL to accommodate sponsor-specific PBMC processing protocols and downstream analytical needs.

About the speaker

Nikola Kolundiz



Dr. Nikola Kolundzic has been a Study Director at REPROCELL since 2021. He has more than 15 years of experience in cell-based assays, in vitro cell culture systems, and immunophenotyping, with special emphasis on stem cell derivation and cultivation, primary cell isolation, and PBMC processing. Currently, he is responsible for performing GCLP studies for REPROCELL's clients.